From the Journals

Fewer GI docs, more alcohol-associated liver disease deaths


 

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Overcoming barriers to care for liver disease

The overall supply of gastroenterologists could be increased by reducing the educational requirements and increasing the funding for fellowships, said Dr. Lee.

“We have to have a better understanding as to the barriers to gastroenterology practice in certain areas, then interventions to address those barriers and also incentives to attract gastroenterologists to those areas,” Dr. Lee said.

The study underscores the importance of access to gastroenterological care, said George Cholankeril, MD, assistant professor of medicine at Baylor College of Medicine, Houston, who was not involved in the study. That urgency has only grown as ALD has spiraled up with the COVID-19 pandemic, he said.

“Anyone in clinical practice right now will be able to say that there’s been a clear rising tide of patients with alcohol-related liver disease,” he told this news organization. “There’s an urgent need to address this and provide the necessary resources.”

Prevention remains essential, Dr. Cholankeril said.

Gastroenterologists and primary care physicians can help stem the tide of ALD by screening their patients for the disease through a tool like AUDIT (Alcohol Use Disorders Identification Test), he said. They can then refer patients to substance abuse treatment centers or to psychologists and psychiatrists.

Dr. Lee and Dr. Cholankeril report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Patient CRC screening preferences don’t match what they’re being offered
MDedge Family Medicine
New blood test could reshape early CRC screening
MDedge Family Medicine
Jury out on synbiotics for kids with GI disorders
MDedge Family Medicine
MERIT: Endoscopic sleeve gastroplasty shows ‘very impressive’ outcomes in randomized clinical trial
MDedge Family Medicine
Docs not talking about anal sex may put women at risk
MDedge Family Medicine
Gut metabolites may explain red meat–ASCVD link
MDedge Family Medicine
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
MDedge Family Medicine
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
MDedge Family Medicine
COVID-19 may trigger irritable bowel syndrome
MDedge Family Medicine
Neighborhood factors contribute to liver cancer disparities in Texas
MDedge Family Medicine